Zinc of Ireland Limited

Zinc of Ireland Limited

AASX:ZMI
0.02
AUD
+0.00
(-5.56%)
-0.01EPS
2.28MMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Revenue per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Basic EPS, GAAP
-9.96
-3.92
-0.3
-0.25
-0.05
-0.01
- -
-0.01
- -
- -
- -
-0.01
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
3.14
-0.84
-0.08
-0.01
0.04
0.05
0.05
0.05
0.05
0.04
0.04
0.03
- -
Tangible Book Value per Share
3.14
-0.84
-0.08
-0.01
0.04
0.05
0.05
0.05
0.05
0.04
0.04
0.03
- -
Basic Weighted Avg Shares
1
1
2
1
71
88
135
154
154
213
265
269
467
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-5
-4
-1
- -
-4
-1
-1
-1
-1
-1
-1
-2
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Working Capital
-1
-1
-1
- -
1
3
3
1
- -
2
1
- -
- -
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
3
-1
-1
- -
2
5
8
7
7
10
10
9
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
-162.07
- -
- -
- -
- -
-29.14
-10.11
-10.81
-8.93
-6.36
-5.14
-17.71
- -

Capital Structure

AUD

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

AUD

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

AUD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
- -
Free Cash Flow
- -
- -
- -
Net Income, GAAP
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

AUD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
- -
2024
- -
- -
- -
2025
- -
- -
- -

Semi-annual Earnings Per Share

AUD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
- -
2024
- -
- -
-0.01
2025
- -
- -
- -

Semi-annual Dividends Per Share

AUD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
- -
2024
- -
- -
- -
2025
- -
- -
- -

Company Description

CEO
Greg Ross
Full Time Employees
- -
Sector
Non-energy minerals
Industry
Other metals/Minerals
Address
28 The Esplanade West Perth WA Australia 6000
IPO Date
Jul 10, 2007
Business
Zinc of Ireland NL (ASX: ZMI) operates as a mineral exploration and development company focused on zinc-lead deposits in the Republic of Ireland and Western Australia. The company explores for high-grade Irish-Type zinc projects, including its flagship Kildare Project comprising contiguous prospecting licenses covering approximately 240 square kilometers located 40 kilometers southwest of Dublin within the Rathdowney base metal trend; the Rathdowney Trend portfolio with 81 prospecting licenses either granted or under offer; the Mt Clere Project in Western Australia featuring the Robin 21 anomaly with broad sulphide mineralization intersections; and the Earaheedy Basin exploration license EL38/3624 granted in November 2021 for a five-year term. Zinc of Ireland also pursues orogenic gold mineralization through its Murchison Gold Project exploration license application ELA 21/230. Incorporated in 2007 and headquartered in Subiaco, Australia, the company conducts operations primarily in Ireland and Australia, targeting zinc, lead, copper, silver and gold deposits with inferred resources at Kildare's McGregor and Shamrock zones. In recent developments, Zinc of Ireland completed a capital raising on 22 August 2024 to fund ongoing activities; reported steady progress in the quarter ending September 2025 including gravity geophysical surveys at Kildare, successful drilling at Mt Clere, and Rathdowney tenure refinement by surrendering less prospective licenses; issued 265,655,351 ordinary shares via a pro rata securities offer; advanced 2025 quarterly results with assays pending and 2026 fully funded for district-wide development; and held its 2025 annual general meeting securing shareholder approval for re-elections, share issues, and a 10% placement facility.